The University of Alabama at Birmingham — Birmingham, Alabama

The University of Alabama at Birmingham is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

The University of Alabama at Birmingham has participated in 124 clinical trials with 38 currently active.

Therapeutic areas: Rheumatoid Arthritis, Adjuvant Arthritis, Pulmonary Arterial Hypertension.

Sponsors: University of Alabama at Birmingham, Lung Biotechnology PBC, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Alabama at Birmingham?

The University of Alabama at Birmingham has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Alabama at Birmingham conducted?

The University of Alabama at Birmingham has 124 clinical trials on record, with 38 currently active. Their work covers Rheumatoid Arthritis, Adjuvant Arthritis, Pulmonary Arterial Hypertension.

Is The University of Alabama at Birmingham accredited by Crixeo Health?

The University of Alabama at Birmingham has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Alabama at Birmingham?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.